🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of the efficacy of CPX-351 treatment in patients with higher risk mye...
Status
Completed
Location
CHU d'Amiens - Service d'hématologie clinique et thérapie cellulaire
Start Date
2020-04-29
Trial ID
NCT04273802
Treatments Being Tested
This study evaluates the pharmacokinetics and safety of CPX-351 in patients...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2018-11-20
Trial ID
NCT03555955
The purpose of the study is to determine the safety of combining the drugs ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-02-16
Trial ID
NCT05558124
Treatments Being Tested
This phase I/II trial finds the highest safe dose of IMGN632 that can be gi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05320380
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested
This is an open label study to assess the safety and efficacy of CPX-351 in...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2019-08-23
Trial ID
NCT03878927
Treatments Being Tested